MML Investors Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $270K | Sell |
4,918
-329
| -6% | -$18.1K | ﹤0.01% | 2491 |
|
2025
Q1 | $371K | Sell |
5,247
-2,292
| -30% | -$162K | ﹤0.01% | 2189 |
|
2024
Q4 | $496K | Sell |
7,539
-82
| -1% | -$5.4K | ﹤0.01% | 1921 |
|
2024
Q3 | $536K | Buy |
7,621
+572
| +8% | +$40.2K | ﹤0.01% | 1817 |
|
2024
Q2 | $580K | Sell |
7,049
-1,273
| -15% | -$105K | ﹤0.01% | 1696 |
|
2024
Q1 | $727K | Sell |
8,322
-4,401
| -35% | -$384K | ﹤0.01% | 1593 |
|
2023
Q4 | $1.23M | Buy |
12,723
+3,719
| +41% | +$359K | 0.01% | 1230 |
|
2023
Q3 | $797K | Buy |
9,004
+550
| +7% | +$48.7K | ﹤0.01% | 1353 |
|
2023
Q2 | $733K | Buy |
8,454
+2,024
| +31% | +$175K | ﹤0.01% | 1397 |
|
2023
Q1 | $625K | Buy |
6,430
+426
| +7% | +$41.4K | ﹤0.01% | 1299 |
|
2022
Q4 | $621K | Buy |
6,004
+78
| +1% | +$8.07K | ﹤0.01% | 1393 |
|
2022
Q3 | $502K | Buy |
5,926
+165
| +3% | +$14K | ﹤0.01% | 1419 |
|
2022
Q2 | $477K | Sell |
5,761
-2,995
| -34% | -$248K | ﹤0.01% | 1434 |
|
2022
Q1 | $675K | Sell |
8,756
-5,214
| -37% | -$402K | ﹤0.01% | 1300 |
|
2021
Q4 | $1.23M | Buy |
13,970
+772
| +6% | +$68.2K | 0.01% | 973 |
|
2021
Q3 | $1.02M | Sell |
13,198
-222
| -2% | -$17.2K | 0.01% | 1006 |
|
2021
Q2 | $1.12M | Buy |
13,420
+2,452
| +22% | +$205K | 0.01% | 952 |
|
2021
Q1 | $828K | Buy |
10,968
+718
| +7% | +$54.2K | 0.01% | 1008 |
|
2020
Q4 | $899K | Sell |
10,250
-257
| -2% | -$22.5K | 0.01% | 885 |
|
2020
Q3 | $799K | Sell |
10,507
-1,202
| -10% | -$91.4K | 0.01% | 856 |
|
2020
Q2 | $1.44M | Sell |
11,709
-809
| -6% | -$99.8K | 0.02% | 608 |
|
2020
Q1 | $1.06M | Buy |
12,518
+290
| +2% | +$24.5K | 0.02% | 604 |
|
2019
Q4 | $1.03M | Buy |
12,228
+251
| +2% | +$21.2K | 0.01% | 707 |
|
2019
Q3 | $807K | Sell |
11,977
-1,560
| -12% | -$105K | 0.01% | 757 |
|
2019
Q2 | $1.16M | Buy |
13,537
+1,810
| +15% | +$155K | 0.02% | 663 |
|
2019
Q1 | $1.04M | Buy |
11,727
+2,545
| +28% | +$226K | 0.02% | 686 |
|
2018
Q4 | $782K | Buy |
9,182
+1,469
| +19% | +$125K | 0.01% | 711 |
|
2018
Q3 | $748K | Buy |
7,713
+3,009
| +64% | +$292K | 0.01% | 799 |
|
2018
Q2 | $443K | Buy |
4,704
+1,905
| +68% | +$179K | 0.01% | 896 |
|
2018
Q1 | $227K | Buy |
+2,799
| New | +$227K | ﹤0.01% | 1210 |
|